Editorial pages offer a variety of views on the pending debate surrounding this Medicaid policy and a range of other health care issues.
from Kaiser Health News http://ift.tt/2DqSF4Y
January 22, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
FDA Weighs Approval of a Lucrative Alzheimer’s Drug but Benefits Are IffyThe Food and Drug Administration’s decision next week whether to approve the first treatment for Alzheimer’s disease highlights a deep division over the drug’s benefits as well as criticism about the integrity of the FDA appr… Read More
Newsom Wants to Spend Millions on the Health of Low-Income Mothers and Their BabiesAmid a pandemic that has pushed millions of mothers out of the workplace, caused fertility rates to plunge and heightened the risk of death for pregnant women, California Gov. Gavin Newsom and Democratic lawmakers are seeking… Read More
KHN’s ‘What the Health?’: The Drug Price DilemmaCan’t see the audio player? Click here to listen on SoundCloud. You can also listen on on Spotify, Apple Podcasts, Stitcher, Pocket Casts or wherever you listen to podcasts. The high cost of prescription drugs … Read More
Analysis: Mounting Pressure on China About Covid ‘Lab Leak’ Could BackfirePresident Joe Biden has ordered U.S. intelligence agencies to determine whether the covid virus, or a near ancestor, emerged from a cave, a live-animal market, a farm — or a secretive Chinese laboratory. Use Our Content It ca… Read More
In Missouri and Other States, Flawed Data Makes It Hard to Track Vaccine EquityThroughout the covid-19 vaccination effort, public health officials and politicians have insisted that providing shots equitably across racial and ethnic groups is a top priority. This story is part of a reporting partnershi… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment